Skip to main content
Prabhu Mathiyalagan on Muck Rack

Prabhu Mathiyalagan

As seen in: Frontiers, BioRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Prabhu

Contact Prabhu, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Single nucleus transcriptomics supports a role for CCNA2-induced human adult cardiomyocyte cytokinesis

|
By Esmaa Bouhamida, Sangeetha Vadakke-Madathil, Prabhu Mathiyalagan, Amaresh K. Ranjan
| BioRxiv
Abstract Cyclin A2 (CCNA2) is a master regulatory gene of the cell cycle that is normally silenced in postnatal mammalian cardiomyocytes. We have previously demonstrated that it can induce significant cardiac repair in both small and large animals when delivered to the heart via a viral vector. To date, whether CCNA2 gene delivery can induce cytokinesis in isolated cardiomyocytes from adult human hearts has not been investigated.
Open in Who Shared Issue with article?

Functional evaluation of constructed pseudo-endogenous microRNA-targeted myocardial ultrasound nanobubble

|
By Prabhu Mathiyalagan, Shizuka Uchida, Malik Bisserier, Ajay Ram Vachanaram
| Frontiers
1. Introduction MiRNAs are small non coding RNAs composed of 21–25 nucleotides, which regulate the myocardial microenvironment at the post transcriptional level (1, 2). Endogenous plasma miRNAs are released into the blood circulation in the form of microcapsules or exosomes (3), which can be protected from the influence of Ribonuclease (RNase) without being degraded, and exist in the circulation in a highly stable form (4).
Open in Who Shared Issue with article?

Regulation of The Methylation and Expression Levels of the BMPR2 Gene by SIN3a As A Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension

|
By Malik Bisserier, Prabhu Mathiyalagan, Shihong Zhang, Firas Elmastour
| AHA/ASA Journals
Abstract Background: Epigenetic mechanisms are critical in the pathogenesis of pulmonary arterial hypertension (PAH). Previous studies have suggested that hypermethylation of the Bone Morphogenetic Protein Receptor Type 2 (BMPR2) promoter is associated with BMPR2 downregulation and progression of PAH.
Open in Who Shared Issue with article?
See all 6 articles